InvestorsHub Logo

foxi

07/17/22 9:17 PM

#155065 RE: Mightymite45 #155061

The valuation is whatever the gamble is worth to speculative investors in light of the current market dynamic and other potential gambles that may pay off sooner.

A valuation gets more concrete when ENZC delivers on anything in its potential pipeline, transforming speculation to certainty.

MAGA_PATRIOT

07/17/22 9:23 PM

#155066 RE: Mightymite45 #155061

Mightymite45 just calculate the numbers we know ($100B over first 11 years = $9.1B per year) and do the math. Add a conservative multiplier if you wish. 18 is avg for bio, so u could use 5-10 for conservative).

9.09B ÷ 2,830,435,953 = $3.21
$3.21 X 6 (Multiplier) = 19.26
The $19.26 is based on C3 mABS for HIV only, using a conservative multiplier of 6.

After that you can take a look at the other products/tech they're trying to bring to market, and look up the size of those markets. Again, just take factor a conservative piece of each market for them, do the math again, and add to the above...

Hope this helps...